This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

The Canadian Task Force On Preventive Health Care Releases Updated Guideline For Cervical Cancer Screening

Task Force says annual screening for asymptomatic women is unnecessary

OTTAWA, Jan. 7, 2013 /CNW/ - The Canadian Task Force on Preventive Health Care (Task Force) today released an updated guideline on cervical cancer screening, recommending women aged 25-69 be screened at an interval of three years. The Task Force, an independent body of fourteen specialists with expertise in prevention, and primary care in Canada, says early and frequent (often annual) cervical screening is unnecessary. The Guideline is published in the Canadian Medical Association Journal - http://www.cmaj.ca/lookup/doi/10.1503/cmaj.121505.

The guideline is an update to that last published by the Task Force in 1994 and is based on the best and latest evidence in cervical cancer screening. Aimed at physicians, policy makers and Canadian women, the updated Guideline identifies the optimal use and frequency of screening (Pap tests) for cervical cancer in asymptomatic women who are or who have been sexually active, regardless of sexual orientation.

"Since the introduction of Pap tests in Canada, the proportion of women getting cervical cancer has declined from 1.5% of all women to 0.66%, and the proportion dying from cervical cancer had declined from 0.94% to 0.22%" said Dr. James Dickinson, member of the Task Force and chair of the guideline working group. "And while it is likely that most of this improvement is a result of screening, other countries have achieved similar outcomes despite initiating screening at an older age and implementing longer screening intervals. Reducing the number of pap tests gives women the benefit from screening, while reducing the inconvenience, discomfort and potential harms caused by early and excessive testing."

The current guideline differs from the previous 1994 CTFPHC recommendations in a number of ways:

  1. The updated Guideline says routine screening is not recommended in sexually active women who are younger than 25. The 1994 Guideline recommended annual screening with Pap tests after initiation of sexual activity or at age 18.
  2. The updated Guideline recommends asymptomatic women aged 25-69 (who are or have been sexually active) be screened at an interval of 3 years. The 1994 Guideline recommended women aged 20-69 be screened every three years - but only after 2 normal Pap tests.
  3. In the updated Guideline, screening is now explicitly recommended in women older than 69, if prior screening has not been adequately performed. In the previous Guideline, screening women aged 70+ was not recommended.

"The greatest reduction in cervical cancer will be achieved by screening more eligible women who have not previously been screened, and not by screening more women earlier or more often," according to the authors of the Guideline. "Identifying the optimal use and frequency of screening will help reduce the inconvenience, discomfort and potential harms caused by early and excessive testing, while still ensuring the greatest benefit from screening."

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,880.36 -31.75 -0.19%
S&P 500 1,970.07 +0.12 0.01%
NASDAQ 4,462.9020 +20.2040 0.45%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs